Results 21 to 30 of about 790,552 (265)

Silent Myocardial Ischemia in Patients after Permanent Coronary Intervention

Архивъ внутренней медицины, 2022
Frequency and timing of appearance of myocardial ischemia, including silent ischemia, were analyzed in published scientific sources. Silent myocardial ischemia is risk factor for stent restenosis after percutaneous coronary interventions.
A. I. Abdrahmanova, N. A. Tsibulkin, N. B. Amirov, I. M. Khabibullin, L. I. Gornaeva, L. A. Galimzyanova, D. S. Elagina   +6 more
doaj   +1 more source

Second-generation extracellular matrix patch for epicardial infarct repair

Journal of Cardiothoracic Surgery, 2023
Current myocardial infarction treatments focus on improving hemodynamics rather than addressing the problem of lost myocardium impairing left ventricular function.
Arjun Bhatt, Michael J. Bates, Constantin B. Marcu, Robert G. Matheny, Blase A. Carabello, Kanhua Yin, Walter Douglas Boyd   +6 more
doaj   +1 more source

Mid-term Results of Hybrid Myocardial Revascolarization for the Patients with the Coronary Arteries Disease

Український журнал серцево-судинної хірургії, 2019
Introduction. Myocardial revascularization using traditional percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is indicated to the patients with multivessel coronary artery (CA) damage. However, complete revascularization
A. Gabrielyan, T. Domansky, О. Beregovoy   +2 more
doaj   +1 more source

Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction [PDF]

Texas Heart Institute Journal
Background This study compared the safety and effectiveness of paclitaxel/cilostazol–eluting Cilotax stents with those of everolimus-eluting stents in patients with acute myocardial infarction.
HyeYon Yu, PhD, Jihun Ahn, MD, PhD, Byoung Geol Choi, PhD, Soohyung Park, MD, Dong Oh Kang, MD, Cheol Ung Choi, MD, Seung-Woon Rha, MD, PhD, Myung Ho Jeong, MD, PhD   +7 more
doaj   +1 more source

Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.

JAMA cardiology, 2020
Importance Recently, the Complete vs Culprit-Only Revascularization to Treat Multivessel Disease After Early PCI (percutaneous coronary intervention) for STEMI (ST-segment elevation myocardial infarction [MI]) (COMPLETE) trial showed that angiography ...
K. Bainey, T. Engstrøm, P. Smits, A. Gershlick, S. James, R. Storey, D. Wood, R. Mehran, J. Cairns, S. Mehta   +9 more
semanticscholar   +1 more source

Myocardial Viability Testing in Patients with Ischemic Cardiomyopathy [PDF]

Zhongguo quanke yixue
Ischemic cardiomyopathy (ICM) is an important cause of heart failure with reduced ejection fraction. Despite the improvement of treatment methods, it still has a high mortality.
SU Lifang, WANG Yanbo, JIANG Yunfa, LIU Changchang, GU Xinshun
doaj   +1 more source

Clinical Relevance of Rehospitalizations for Unstable Angina and Unplanned Revascularization Following Acute Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundRehospitalizations following acute myocardial infarction for unplanned coronary revascularization and unstable angina (UA) are often included as parts of composite end points in clinical trials.
Supriya Shore, Kim G. Smolderen, John A. Spertus, Kevin F. Kennedy, Philip G. Jones, Zhenxiang Zhao, Tracy Y. Wang, Suzanne V. Arnold   +7 more
doaj   +1 more source

'Ten Commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.

European Heart Journal, 2018
The 2018 ESC/EACTS Guidelines on Myocardial Revascularization were developed by a joint effort of the European Society of Cardiology (ESC) and the European Association of Cardiovascular Surgery (EACTS).
F. Neumann, M. Sousa‐Uva
semanticscholar   +1 more source

Complete Revascularization with Multivessel PCI for Myocardial Infarction.

New England Journal of Medicine, 2019
BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction.
S. Mehta, D. Wood, R. Storey, R. Mehran, K. Bainey, Helen Nguyen, Brandi Meeks, G. di Pasquale, J. López-Sendón, D. Faxon, L. Mauri, S. Rao, L. Feldman, P. Steg, Á. Avezum, T. Sheth, N. Pinilla-Echeverri, R. Moreno, G. Campo, B. Wrigley, S. Kedev, A. Sutton, R. Oliver, J. Rodés‐Cabau, G. Stanković, R. Welsh, S. Lavi, W. Cantor, Jia Wang, J. Nakamya, S. Bangdiwala, J. Cairns   +31 more
semanticscholar   +1 more source

Myocardial protection during myocardial revascularization: Preductal®MR

Медицинский совет, 2013
Myocardial revascularization procedures (coronary artery bypass surgery, percutaneous coronary intervention) raise the question of protecting the myocardium. Trimetazidine is an adequate method of myocardial protection.
Editorial Article
doaj   +1 more source